Nuwellis, Inc.

NUWE

Healthcare Medical Devices

Nuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024.

Revenue
+14.1%
EPS
+98.8%
Free cash flow
−51.6%

Quarter to June 2026, against a year earlier

4.58 0.08 −1.72%
Market cap
$2.5M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
0.1×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.06 0.25 0.15 0.35
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(0.17) (0.70) (0.40) (0.91)
P/B ratio
0.00 0.82 0.46 0.73
EV/Sales
0.06 0.46 0.49 0.45
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(0.05) (0.35) (0.37) (0.39)
Current Ratio
1.97 1.56 1.71 2.04
Net Debt/EBITDA
1.25 0.46 0.42 1.24
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(2,932.14%) (5,979.24%) (5,144.23%) (2,727.67%)
Free Cash Flow Yield
(2,297.98%) (531.18%) (906.97%) (330.15%)
Free Cash Flow per Share
(158.41) (489.70) (1,371.82) (1,201.85)
Book value per Share
(101.74) 404.39 1,195.45 1,447.41
Free Cash Flow
(3.18) (3.23) (3.02) (3.24)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026